Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis

• Jin-Hang Gao ,

  Contributed equally to this work with: Jin-Hang Gao, Shi-Lei Wen

  Affiliations Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China, Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Shi-Lei Wen ,

  Contributed equally to this work with: Jin-Hang Gao, Shi-Lei Wen

  Affiliations Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Wen-Juan Yang,

  Affiliation Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Yao-Yao Lu,

  Affiliation Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Huan Tong,

  Affiliation Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Zhi-Yin Huang,

  Affiliation Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Zhang-Xu Liu,

  Affiliation Research Center for Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Cheng-Wei Tang

  * E-mail: shcqcdmed@163.com

  Affiliations Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China, Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China

  ⨯